1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neurotechnology Device Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Neurotechnology Device by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Neurotechnology Device by Country/Region, 2018, 2022 & 2029
2.2 Neurotechnology Device Segment by Type
2.2.1 Neuroprosthetics
2.2.2 Neural Stimulators
2.2.3 Neurorehabilitation
2.2.4 Neurosensing
2.3 Neurotechnology Device Sales by Type
2.3.1 Global Neurotechnology Device Sales Market Share by Type (2018-2023)
2.3.2 Global Neurotechnology Device Revenue and Market Share by Type (2018-2023)
2.3.3 Global Neurotechnology Device Sale Price by Type (2018-2023)
2.4 Neurotechnology Device Segment by Application
2.4.1 Parkinson’s Disease
2.4.2 Cerebral Palsy
2.4.3 Cognitive Disorders
2.4.4 Epilepsy
2.4.5 Incontinence
2.4.6 Traumatic Brain Injury
2.4.7 Others
2.5 Neurotechnology Device Sales by Application
2.5.1 Global Neurotechnology Device Sale Market Share by Application (2018-2023)
2.5.2 Global Neurotechnology Device Revenue and Market Share by Application (2018-2023)
2.5.3 Global Neurotechnology Device Sale Price by Application (2018-2023)
3 Global Neurotechnology Device by Company
3.1 Global Neurotechnology Device Breakdown Data by Company
3.1.1 Global Neurotechnology Device Annual Sales by Company (2018-2023)
3.1.2 Global Neurotechnology Device Sales Market Share by Company (2018-2023)
3.2 Global Neurotechnology Device Annual Revenue by Company (2018-2023)
3.2.1 Global Neurotechnology Device Revenue by Company (2018-2023)
3.2.2 Global Neurotechnology Device Revenue Market Share by Company (2018-2023)
3.3 Global Neurotechnology Device Sale Price by Company
3.4 Key Manufacturers Neurotechnology Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurotechnology Device Product Location Distribution
3.4.2 Players Neurotechnology Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Neurotechnology Device by Geographic Region
4.1 World Historic Neurotechnology Device Market Size by Geographic Region (2018-2023)
4.1.1 Global Neurotechnology Device Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Neurotechnology Device Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Neurotechnology Device Market Size by Country/Region (2018-2023)
4.2.1 Global Neurotechnology Device Annual Sales by Country/Region (2018-2023)
4.2.2 Global Neurotechnology Device Annual Revenue by Country/Region (2018-2023)
4.3 Americas Neurotechnology Device Sales Growth
4.4 APAC Neurotechnology Device Sales Growth
4.5 Europe Neurotechnology Device Sales Growth
4.6 Middle East & Africa Neurotechnology Device Sales Growth
5 Americas
5.1 Americas Neurotechnology Device Sales by Country
5.1.1 Americas Neurotechnology Device Sales by Country (2018-2023)
5.1.2 Americas Neurotechnology Device Revenue by Country (2018-2023)
5.2 Americas Neurotechnology Device Sales by Type
5.3 Americas Neurotechnology Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurotechnology Device Sales by Region
6.1.1 APAC Neurotechnology Device Sales by Region (2018-2023)
6.1.2 APAC Neurotechnology Device Revenue by Region (2018-2023)
6.2 APAC Neurotechnology Device Sales by Type
6.3 APAC Neurotechnology Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Neurotechnology Device by Country
7.1.1 Europe Neurotechnology Device Sales by Country (2018-2023)
7.1.2 Europe Neurotechnology Device Revenue by Country (2018-2023)
7.2 Europe Neurotechnology Device Sales by Type
7.3 Europe Neurotechnology Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Neurotechnology Device by Country
8.1.1 Middle East & Africa Neurotechnology Device Sales by Country (2018-2023)
8.1.2 Middle East & Africa Neurotechnology Device Revenue by Country (2018-2023)
8.2 Middle East & Africa Neurotechnology Device Sales by Type
8.3 Middle East & Africa Neurotechnology Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurotechnology Device
10.3 Manufacturing Process Analysis of Neurotechnology Device
10.4 Industry Chain Structure of Neurotechnology Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurotechnology Device Distributors
11.3 Neurotechnology Device Customer
12 World Forecast Review for Neurotechnology Device by Geographic Region
12.1 Global Neurotechnology Device Market Size Forecast by Region
12.1.1 Global Neurotechnology Device Forecast by Region (2024-2029)
12.1.2 Global Neurotechnology Device Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Neurotechnology Device Forecast by Type
12.7 Global Neurotechnology Device Forecast by Application
13 Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Neurotechnology Device Product Portfolios and Specifications
13.1.3 Abbott Laboratories Neurotechnology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 Advanced Bionics
13.2.1 Advanced Bionics Company Information
13.2.2 Advanced Bionics Neurotechnology Device Product Portfolios and Specifications
13.2.3 Advanced Bionics Neurotechnology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Advanced Bionics Main Business Overview
13.2.5 Advanced Bionics Latest Developments
13.3 Axonics Modulation Technologies
13.3.1 Axonics Modulation Technologies Company Information
13.3.2 Axonics Modulation Technologies Neurotechnology Device Product Portfolios and Specifications
13.3.3 Axonics Modulation Technologies Neurotechnology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Axonics Modulation Technologies Main Business Overview
13.3.5 Axonics Modulation Technologies Latest Developments
13.4 Boston Scientific Corp
13.4.1 Boston Scientific Corp Company Information
13.4.2 Boston Scientific Corp Neurotechnology Device Product Portfolios and Specifications
13.4.3 Boston Scientific Corp Neurotechnology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Boston Scientific Corp Main Business Overview
13.4.5 Boston Scientific Corp Latest Developments
13.5 Laborie
13.5.1 Laborie Company Information
13.5.2 Laborie Neurotechnology Device Product Portfolios and Specifications
13.5.3 Laborie Neurotechnology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Laborie Main Business Overview
13.5.5 Laborie Latest Developments
13.6 Cleveland Medical Devices
13.6.1 Cleveland Medical Devices Company Information
13.6.2 Cleveland Medical Devices Neurotechnology Device Product Portfolios and Specifications
13.6.3 Cleveland Medical Devices Neurotechnology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Cleveland Medical Devices Main Business Overview
13.6.5 Cleveland Medical Devices Latest Developments
13.7 EndoStim
13.7.1 EndoStim Company Information
13.7.2 EndoStim Neurotechnology Device Product Portfolios and Specifications
13.7.3 EndoStim Neurotechnology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 EndoStim Main Business Overview
13.7.5 EndoStim Latest Developments
13.8 LivaNova
13.8.1 LivaNova Company Information
13.8.2 LivaNova Neurotechnology Device Product Portfolios and Specifications
13.8.3 LivaNova Neurotechnology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 LivaNova Main Business Overview
13.8.5 LivaNova Latest Developments
13.9 Medtronic
13.9.1 Medtronic Company Information
13.9.2 Medtronic Neurotechnology Device Product Portfolios and Specifications
13.9.3 Medtronic Neurotechnology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Medtronic Main Business Overview
13.9.5 Medtronic Latest Developments
13.10 Natus Medical Incorporated
13.10.1 Natus Medical Incorporated Company Information
13.10.2 Natus Medical Incorporated Neurotechnology Device Product Portfolios and Specifications
13.10.3 Natus Medical Incorporated Neurotechnology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Natus Medical Incorporated Main Business Overview
13.10.5 Natus Medical Incorporated Latest Developments
13.11 Neuronetics
13.11.1 Neuronetics Company Information
13.11.2 Neuronetics Neurotechnology Device Product Portfolios and Specifications
13.11.3 Neuronetics Neurotechnology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Neuronetics Main Business Overview
13.11.5 Neuronetics Latest Developments
13.12 NeuroSigma
13.12.1 NeuroSigma Company Information
13.12.2 NeuroSigma Neurotechnology Device Product Portfolios and Specifications
13.12.3 NeuroSigma Neurotechnology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 NeuroSigma Main Business Overview
13.12.5 NeuroSigma Latest Developments
13.13 Restorative Therapies
13.13.1 Restorative Therapies Company Information
13.13.2 Restorative Therapies Neurotechnology Device Product Portfolios and Specifications
13.13.3 Restorative Therapies Neurotechnology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Restorative Therapies Main Business Overview
13.13.5 Restorative Therapies Latest Developments
13.14 Zynex Medical
13.14.1 Zynex Medical Company Information
13.14.2 Zynex Medical Neurotechnology Device Product Portfolios and Specifications
13.14.3 Zynex Medical Neurotechnology Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Zynex Medical Main Business Overview
13.14.5 Zynex Medical Latest Developments
14 Research Findings and Conclusion
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer